健保藥品的HTA評估報告
- 61 Remsima Solution for Injection
- 62 Cosentyx 150mg/mL solution for injection、150mg powder for solution for injection
- 63 Tractocile
- 64 Betosiban concentrate for solution for infusion 7.5mg/ml
- 65 Tremfya Solution for Injection 100mg/mL
- 66 奔麗生凍晶注射劑 (Benlysta Powder for Solution for Infusion)
- 67 修訂Cholic acid (如Cholbam) 藥品給付規定
- 68 Otezla Film-coated Tablets 30mg
- 69 Cretrol
- 70 貝瑞酶凍晶注射劑 (Nexviazyme 10 mg/mL Powder for Concentrate for Solution for Infusion)
- 71 Trelegy Ellipta 92/55/22 mcg Inhalation Powder、Trelegy Ellipta 184/55/22 mcg Inhalation Powder
- 72 Otezla Film-coated Tablets 30mg
- 73 偉卡沃膜衣錠 (Verquvo)
- 74 舒肺樂凍晶注射劑 (Nucala Power for Solution for Injection)
- 75 達伯坦錠 (Pemazyre Tablets)
- 76 Verquvo 2.5mg、5mg 及10mg film-coated tablets
- 77 Romiplate 250μg injection
- 78 Refixia powder and solvent for solution for injection
- 79 擴增含eftrenonacog alfa 成分藥品(如Alprolix)之給付範圍
- 80 BREZTRI AEROSPHERE